The Swiss Market Index plummeted over 5% as US President Trump's announcement of major tariffs on pharmaceuticals led to a selloff in Swiss pharma stocks, with Novartis and Roche a...
The Swiss Market Index fell over 5% as US tariffs on pharmaceuticals sparked a selloff in Swiss pharma stocks, with Novartis and Roche shares dropping significantly.
The Swiss Market Index (SMI) fell over 5% due to US trade war escalation, particularly affecting the pharmaceutical sector after President Trump announced a major tariff on pharmac...
The Swiss Market Index plunged over 5% as US President Donald Trump's announcement of major tariffs on pharmaceuticals caused a selloff in Swiss pharma stocks, with Novartis and Ro...
The Swiss Market Index dropped over 5% as US tariff threats on pharmaceuticals caused a selloff, significantly affecting Swiss pharma companies like Novartis and Roche.
The Swiss Market Index dropped over 5% following US President Donald Trump's announcement of major tariffs on pharmaceuticals, causing significant losses for Swiss pharma giants No...
The Swiss Market Index dropped 5% following new U.S. tariffs, with a 31% duty on Swiss exports. The Swiss franc gained strength against the dollar and euro amidst the market turmoi...
Switzerland's SMI drops 5% following US tariff announcements, with a 31% duty on Swiss exports to the US. The Swiss franc gains strength amidst market uncertainty.
